학술논문
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Advanced NSCLC
Document Type
Article
Author
Source
In: JTO Clinical and Research Reports . (JTO Clinical and Research Reports, March 2023, 4(3))
Subject
Language
English
ISSN
26663643